The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
A Randomized, Double-Blind, Placebo-Controlled Trial of Metformin Treatment of Weight Gain Associated With Initiation of Atypical Antipsychotic Therapy in Children and Adolescents
Abstract
OBJECTIVE: Second-generation, or atypical, antipsychotics effectively treat psychiatric illness in children and adolescents. However, weight gain and abnormalities in insulin sensitivity, including diabetes, complicate this therapy. METHOD: A 16-week double-blind, placebo-controlled trial was conducted to evaluate the effectiveness of metformin in managing weight gain in 39 subjects, ages 10-17, whose weight had increased by more than 10% during less than 1 year of olanzapine, risperidone, or quetiapine therapy. Body weight, body mass index (kilograms per square meter of height), and waist circumference were measured regularly, as were fasting insulin and glucose levels. RESULTS: Weight was stabilized in subjects receiving metformin, while those receiving placebo continued to gain weight (0.31 kg/week). Because the study was conducted with growing children, metformin treatment resulted in reduction in z scores for both weight and body mass index. The homeostasis model assessment, a surrogate indicator of insulin sensitivity, decreased in treated subjects. Overt diabetes was diagnosed in two subjects before treatment (elevated baseline fasting glucose and insulin values) and in two placebo-treated subjects (one at week 12 and the other after study completion). One subject taking placebo developed impaired fasting glucose. Placebo treatment was associated with the need to perform oral glucose tolerance testing upon study completion, by which three additional subjects were identified with impaired glucose tolerance. No serious adverse events resulted from metformin treatment. CONCLUSIONS: Metformin therapy is safe and effective in abrogating weight gain, decreased insulin sensitivity, and abnormal glucose metabolism resulting from treatment of children and adolescents with atypicals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
CDC GROWTH CHARTS FOR THE UNITED STATES: METHODS AND DEVELOPMENT 2000
Kuczmarski, R. J., Ogden, C. L., Guo, S. S., Strawn, L. G., Flegal, K. M., & Mei, Z. (2002) · Cited by 6,426
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
Davis, J. M., Chen, N., & Glick, I. D. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.553 · Cited by 1,034
Randomized Trial of Lifestyle Modification and Pharmacotherapy for Obesity
Wadden, T. A., Berkowitz, R. I., Womble, L. G., Sarwer, D. B., Phelan, S., Cato, R. K., Hesson, L. A., Osei, S. Y., Kaplan, R., & Stunkard, A. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050156 · Cited by 794
Freemark, M., & Bursey, D. (2001) · Pediatrics · doi:10.1542/peds.107.4.e55 · Cited by 433
Henderson, D. C., Cagliero, E., Copeland, P. M., Borba, C. P., Evins, A. E., Hayden, D., Weber, M. T., Anderson, E. J., Allison, D. B., Daley, T. B., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.1.19 · Cited by 319
Trends in the Use of Typical and Atypical Antipsychotics in Children and Adolescents
Patel, N. C., Crismon, M. L., Hoagwood, K., Johnsrud, M. T., Rascati, K. L., Wilson, J. P., & Jensen, P. S. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000157543.74509.c8 · Cited by 186
Metformin for Weight Loss in Pediatric Patients Taking Psychotropic Drugs
Morrison, J. A., Cottingham, E. M., & Barton, B. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.655 · Cited by 174
Self-citationAder, M., Kim, S. P., Catalano, K. J., Ionut, V., Hucking, K., Richey, J. M., Kabir, M., & Bergman, R. N. (2005) · Diabetes · doi:10.2337/diabetes.54.3.862 · Cited by 166
Morrison, J. A., BARTON, B. A., Biro, F. M., Sprecher, D. L., Falkner, F., & Obarzanek, E. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83176-2 · Cited by 142
Self-citationMackin, P., Watkinson, H., & Young, A. H. (2005) · Diabetologia · doi:10.1007/s00125-004-1641-y · Cited by 138
Use of antipsychotics in children and adolescents.
Findling, R. L., Steiner, H., & Weller, E. B. (2005) · PubMed · Cited by 134
Sowell, M. O., Mukhopadhyay, N. D., Cavazzoni, P. A., Shankar, S. S., Steinberg, H. O., Breier, A. F., Beasley, C. M., & Dananberg, J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8599 · Cited by 129
A Double-Blind, Placebo-Controlled Trial of Sibutramine for Olanzapine-Associated Weight Gain
Henderson, D. C., Copeland, P. M., Daley, T. B., Borba, C. P. C., Cather, C., Nguyen, D. D., Louie, P. M., Evins, A. E., Freudenreich, O., Hayden, D. L., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.5.954 · Cited by 126
Weight Gain in Adolescents Treated with Risperidone and Conventional Antipsychotics Over Six Months
Kelly, D. L., Conley, R. R., Love, R. C., HORN, D. S., & USHCHAK, C. M. (1998) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1998.8.151 · Cited by 111
Options for pharmacological management of obesity in patients treated with atypical antipsychotics
Werneke, U., Taylor, D. M., & Sanders, T. A. B. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200207000-00001 · Cited by 94
Graham, K. A., Gu, H., Lieberman, J. A., Harp, J. B., & Perkins, D. O. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.9.1744 · Cited by 92
Combining Behavioral and Pharmacological Treatments for Obesity
Phelan, S., & Wadden, T. A. (2002) · Obesity Research · doi:10.1038/oby.2002.77 · Cited by 82
Klein, D. J., Friedman, L. A., Harlan, W. R., BARTON, B. A., Schreiber, G. B., Cohen, R. M., Harlan, L. C., & Morrison, J. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.378 · Cited by 68
Self-citationCanitano, R. (2004) · Brain and Development · doi:10.1016/j.braindev.2004.06.006 · Cited by 63
Prevalence of Atypical Antipsychotic Drug Use Among Commercially Insured Youths in the United States
Curtis, L. H., Masselink, L. E., Østbye, T., Hutchison, S., Dans, P. E., Wright, A., Krishnan, R. R., & Schulman, K. A. (2005) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.159.4.362 · Cited by 49
Pharmacotherapy of Pervasive Developmental Disorders in Children and Adolescents
Masi, G. (2004) · CNS Drugs · doi:10.2165/00023210-200418140-00006 · Cited by 35
Benefits of Lifestyle Modification in the Pharmacologic Treatment of Obesity: A Randomized Trial
Wadden, T. A., Berkowitz, R. I., Sarwer, D. B., Prus-Wisniewski, R., & Steinberg, C. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.2.218 · Cited by 1
Research works printed but not linked: 3
- Findling RL, 2005, J Clin Psychiatry, 66, 29
- 10.1345/aph.1D423a · doi:10.1345/aph.1d423a
- American Diabetes Association, 2006, Diabetes Care, 28, S1
Cited by
Styne, D. M., Arslanian, S. A., Connor, E. L., Farooqi, I. S., Murad, M. H., Silverstein, J. H., & Yanovski, J. A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2573 · Cited by 1,282
Wu, R.-R., Zhao, J.-P., Jin, H., Shao, P., Fang, M.-S., Guo, X.-F., He, Y.-Q., Liu, Y.-J., Chen, J.-D., & Li, L.-H. (2008) · JAMA · doi:10.1001/jama.2007.56-b · Cited by 366
De Hert, M., Dobbelaere, M., Sheridan, E. M., Cohen, D., & Correll, C. U. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2010.09.011 · Cited by 362
Sacher, P. M., Kolotourou, M., Chadwick, P. M., Cole, T. J., Lawson, M. S., Lucas, A., & Singhal, A. (2010) · Obesity · doi:10.1038/oby.2009.433 · Cited by 337
Cooper, S. J., Reynolds, G. P., order):, W. E. C.-A. (. A., Barnes, T., England, E., Haddad, P., Heald, A., Holt, R., Lingford-Hughes, A., Osborn, D., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116645254 · Cited by 292
Metadata
- Authors
- Klein, D. J., Cottingham, E. M., Sorter, M., Barton, B. A., & Morrison, J. A.
- Venue
- American Journal of Psychiatry
- Published
- 2006-12
- Volume
- 163
- Issue
- 12
- Pages
- 2072-2079
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2170708988
- Cited by
- 271
- References
- 25
- FWCI
- 14.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.